The articles in this issue on the prevalence of systemic lupus erythematosus (SLE) in the United States1.2 should intrigue all those interested in lupus. With caveats, both studies basically come to the same conclusion albeit differing in their estimates: based on selfreported physician diagnoses of SLE, the current reported prevalence rates underestimate the actual prevalence considerably. They revive the debate between advocacy groups who would wish that SLE receive more attention and those who emphasize the need for using objective criteria for its diagnosis. Lahita's study uses a probability sample. Hochberg does not specify precisely the sampling strategy used but since subjects not matched by race or age were excluded and the vast majority were in California, Maryland and Pennsylvania one guesses that the resultant sample was neither a probability nor a simple random sample.
Non-response bias in surveys affects the generalizability of the results to the population from which the sample is drawn. In phone surveys, the percentage of households with phones, when the calls are made, how many rings and calls are attempted, and how the questions are worded, are all factors which influence who answers, who refuses, the responses given, and who is studied, in fact. Of particular importance are how nonresponders are dealt with in the study (a favourite tactic is to replace them with another sample assembled by the same procedures) or analytically. Non-response must be assumed to bias the results until proven otherwise. Lahita's response rate is not given; Hochberg's is 74% when one combines the exclusions and the nonrespondents. Non-response might over or undercount SLE depending on the reason for non-response. If sick SLE subjects are less likely to have phones (for instance, those with lower socioeconomical status) the numbers might be higher. One suspects that the biases are conservative and would lead to an underestimate.
Using physician-diagnosed lupus assumes access to a physician (for which some 37 million Americans are uninsured!) and that the physician's diagnosis is correct.
Its effect on ascertainment is inscrutable in a relatively unusual disease such as SLE.
Samples of even large numbers of subjects are probably not large enough in a relatively usual disorder as lupus, contributing to the observed wide confidence intervals. The difference in sample size explains the narrower confidence interval in the Hochberg study compared to the Lahita study. In etiologic and descriptive epidemiology of rare diseases, complete surveys in contrast to random samples have been recommended for this very reason. A study by McCarthy, et al, describing the use of a capture/recapture technique has relevance to this problem and may provide a practical, economical way to avoid missing cases from random samples of the population'.
Methodological details aside, some data is preferred to opinion. Confirmatory studies increase one's confidence in drawing conclusions from individual albeit imperfect ones. The conclusions raise interesting questions.
The authors point out the difficulties of using selfreport of a physician's diagnosis of lupus as a way of assessing prevalence. Self-reported symptoms are useful for identifying subjects for more detailed evaluation4.5 and self-reported diagnoses are useful for describing the burden of disease on the population. The people who believe they have lupus or who have been told by their physician they have lupus suffer, incur health care costs and present problems to their families, their physicians, and society. Studies suggest that the number of individuals in the general population who have lupus with almost ACR criteria nearly equals that of people who meet stringent ACR criteria'. Other studies show that most patients who have some ACR criteria of lupus or who have suspected lupus evolve ACR criteria eventually and become 'validated cases,7,8.
The interpretation that the high rate of self-reported physician diagnosed patients might be due to erroneous diagnoses is a hypothesis worthy of further study. Clinicians certainly recognize the phenomenon of the patient with vague symptoms who is inappropriately labeled as having SLE because of a weekly positive antinuclear antibody found in shotgun laboratory testing or from 'rheumatic disease panels' offered by commercial laboratories. Some patients are also inappropriately treated. Our experience is that 70% of the self-reported physician diagnosed SLE in medically sophisticated subjects, nurses, meet ACR criteria'.
The purpose of epidemiology is not to make more refined counts. Using standardized case definitions in contrast to clinical diagnoses, populations or areas with different rates can be further studied to find clues regarding etiology or risk factors responsible for the variation. For studying etiological hypotheses, having well-defined, homogeneous groups of subjects is important. For social, health and research policy and decisions about resource allocation whether or not these cases are homogeneous or meet ACR criteria is less important, and we argue, immaterial.
